North America Point Care Testing Poct Market
市场规模（十亿美元）
CAGR :
% 
USD
25.20 Billion
USD
52.47 Billion
2025
2033
 Forecast Period |
2026 –2033 |
 Market Size (Base Year) |
USD 25.20 Billion |
 Market Size (Forecast Year) |
USD 52.47 Billion |
 CAGR |
% |
| Major Markets Players |
|
北美即時檢測 (POCT) 市場，按產品類型（血糖監測產品、傳染病檢測產品、心血管代謝監測產品、懷孕和生育力檢測產品、血液學檢測產品、凝血監測產品、濫用藥物 (DOA)檢測產品、尿液分析檢測產品、膽固醇檢測產品、腫瘤/癌症標記檢測產品、糞便隱血試驗產品及其他）、平台（側向流動檢測/免疫層析檢測、免疫分析、試紙條、分子診斷、臨床化學檢測、微流控技術、血液學及其他）、應用（血糖、傳染病、生命徵象監測、心臟監測、微流控技術、血液學及其他）、應用（血糖、傳染病、生命徵象監測、心臟監測、血液監測、無創監測創二氧化碳分壓監測、全血分析及其他）和處方模式劃分（處方檢測和非處方檢測，按最終用戶（醫院、家庭護理機構、診所、實驗室、診斷中心、病理實驗室、門診手術中心、老年護理中心等）、分銷渠道（直接招標、零售、在線銷售等）、國家/地區（美國、加拿大、墨西哥）劃分－行業趨勢和
北美即時檢測（POCT）市場規模
- 2025年北美即時檢測（POCT）市場規模為252億美元 ，預計 到2033年將達到524.7億美元，預測期內 複合年增長率為9.6%。
- 北美即時檢測 (POCT) 市場的成長主要受以下因素驅動：對快速診斷解決方案的需求日益增長，這些方案能夠幫助臨床醫生立即做出決策，並減少對集中式實驗室檢測的依賴。 POCT 設備能夠縮短檢測週轉時間，實現疾病早期發現，並改善患者預後，這在急診、遠距醫療和居家監測中至關重要。
- 糖尿病、心血管疾病、傳染病和呼吸系統疾病等慢性病的日益普遍，顯著推動了即時檢測（POCT）設備在即時監測和管理方面的應用。此外，診斷技術、微流控技術、生物感測器和互聯醫療平台的進步，提高了檢測設備的準確性、便攜性和數據整合能力，從而促進了市場成長。
北美即時檢測（POCT）市場分析
- 北美即時檢測（POCT）市場是診斷行業中一個快速成長的細分領域，可在診所、醫院、救護車和家庭等患者所在場所直接提供即時檢測結果。 POCT設備可快速篩檢和監測包括糖尿病、傳染病、懷孕、心臟標記、電解質失衡和凝血參數在內的多種疾病，從而提高臨床效率並減輕醫療保健系統的負擔。
- 便攜式和易用型診斷技術的需求日益增長，主要受慢性病盛行率上升、急診需求增加以及居家患者監測普及的推動。此外，數位健康平台、智慧型手機診斷、人工智慧檢測和無線連接的整合，有助於提高數據可追溯性和遠端患者管理能力，從而進一步促進市場成長。
- 預計到 2026 年，美國將主導北美即時檢測 (POCT) 市場，佔據約 83.12% 的最大收入份額，這主要得益於主要市場參與者的強大影響力、高昂的醫療保健支出、先進的醫療基礎設施以及醫院和家庭護理環境中創新診斷技術的日益普及。
- 預計到 2026 年，血糖監測產品細分市場將佔據北美 POCT 市場的主導地位，市場份額將超過 38.86%，這主要得益於糖尿病患者人數的增加、對即時監測設備的偏好，以及家庭護理患者越來越多地使用便攜式血糖儀和連續血糖監測工具。
報告範圍及北美即時檢測（POCT）市場細分
|
屬性 |
北美即時檢測 (POCT) 市場關鍵洞察 |
|
涵蓋部分 |
|
|
覆蓋國家/地區 |
北美洲
|
|
主要市場參與者 |
|
|
市場機遇 |
|
|
加值資料資訊集 |
除了對市場狀況（如市場價值、成長率、細分、地理覆蓋範圍和主要參與者）的洞察之外，Data Bridge Market Research 精心編制的市場報告還包括創新追蹤和策略分析、技術進步、氣候變遷情境、供應鏈分析、價值鏈分析、供應商選擇標準、PESTLE 分析、波特五力框架分析、專利分析、企業生態系統分析、企業覆蓋範圍、市場分析、市場影響 |
北美即時檢測（POCT）市場趨勢
“透過研發和數位融合實現技術進步和功能擴展”
- 北美即時檢測 (POCT) 市場的一大快速發展趨勢是，企業越來越重視創新、研發和先進診斷技術，旨在提高檢測的準確性、速度、便攜性和即時決策能力。隨著對分散式和以患者為中心的檢測需求不斷增長，醫療服務提供者、診斷公司和醫療器材製造商正大力投資於下一代 POCT 平台，以支持精準診斷並增強跨醫療環境的連接性。
- 雅培、羅氏、西門子醫療、丹納赫和賽默飛世爾科技等業界領導企業正在加速研發，致力於開發微型化設備、晶片實驗室技術和人工智慧檢測系統，以便在需要時提供實驗室級的檢測結果。這些技術進步還包括自動化樣本處理、更高的生物感測器靈敏度和多重檢測能力，從而能夠同時檢測多種生物標記。
- 在傳染病診斷領域，大量的研發工作致力於開發快速、高精度、短時且適用於緊急情況和疫情爆發的分子檢測解決方案。針對流感、新冠肺炎、呼吸道感染、愛滋病和敗血症等疾病設計的即時檢測（POCT）設備正透過微流控和等溫擴增技術進行改進，從而能夠在中心實驗室之外進行可靠的檢測。
- 在慢性病管理領域，血糖監測、心臟生物標記檢測、凝血檢測和腎功能分析等方面的創新正在支持持續監測，並為臨床幹預提供即時數據。各公司正在整合行動應用程式、雲端報告和穿戴式診斷技術，以實現無縫的居家監測和遠距醫療連接。
- 個人化診斷市場也在蓬勃發展，即時檢測（POCT）解決方案正被開發用於腫瘤學、生育力、胃腸道疾病和代謝性疾病篩檢。這些創新旨在實現更早的疾病檢測、更快的治療決策和更好的臨床療效，尤其是在門診和家庭護理環境中。
- 此外，連網設備、數位資料分析和人工智慧驅動的解讀技術的融合，正在建立更智慧的即時檢測（POCT）生態系統，從而提升工作流程自動化水平並減少人為錯誤。這些進步正將POCT轉變為多功能、智慧化的診斷工具，能夠支援預防保健、精準醫療和人群健康管理。
- 這種快速發展、創新驅動的環境正在重塑即時檢測（POCT）市場，推動產業轉型為便攜式、整合和以患者為中心的診斷系統。隨著北美醫療保健系統將效率、可及性和永續性置於優先地位，研發驅動的數位轉型有望催生新的應用，並擴大其在已開發地區和新興地區的市場滲透率。
北美即時檢測（POCT）市場動態
司機
“對快速、分散式和以患者為中心的診斷解決方案的需求日益增長”
- 推動北美即時檢測 (POCT) 市場成長的重要因素之一是對快速、便利且分散的診斷工具日益增長的需求，這些工具能夠改善臨床決策和患者預後。隨著醫療保健系統向以價值為導向、以患者為中心的模式轉型，POCT 可在診療現場或附近提供即時檢測結果，從而減少對中心實驗室的依賴，並實現早期診斷和及時治療幹預。
- 雅培、羅氏、西門子醫療和丹納赫等業界領導者正積極加大研發投入，開發便攜式、高精度、數位化連接的即時檢測（POCT）設備，以支援在醫院、診所、急診室和家庭護理環境中進行即時診斷。這些創新符合市場對整合式數位醫療解決方案、遠距醫療拓展以及人工智慧輔助結果解讀日益增長的需求。
- 在慢性病管理領域，由於北美地區糖尿病、心血管疾病和生活方式疾病的盛行率不斷上升，用於血糖監測、心臟生物標記檢測、凝血功能檢測和腎功能評估的即時檢測（POCT）設備正經歷快速成長。同樣，用於檢測新冠病毒、流感、敗血症、瘧疾和愛滋病毒的傳染病即時檢測系統也正成為疫情控制的關鍵工具，尤其是在資源匱乏的地區。
- 人們越來越重視居家和遠端患者監測，這推動了相關技術的普及，智慧型手機診斷、穿戴式檢測解決方案、雲端平台和遠端報告功能的發展也增強了臨床連接性和護理的連續性。
- 隨著醫療基礎設施現代化、對快速診斷的日益重視以及公共和私人領域的大力投資，即時檢驗（POCT）正成為未來醫療服務的重要組成部分。隨著效率和可近性成為北美醫療改革的核心，對創新、精準且以患者為中心的即時檢驗系統的需求預計將顯著增長。
克制/挑戰
“高成本、監管複雜性以及準確性和標準化問題”
- 儘管市場成長強勁，但北美即時檢測 (POCT) 市場仍面臨許多挑戰，包括設備和檢測成本高昂、監管審批流程嚴格以及不同設備平台診斷準確性存在差異。確保分析性能與集中式實驗室標準相媲美仍然是一項關鍵障礙，尤其是在 POCT 擴展到重症監護和高複雜度檢測領域。
- 獲得FDA、EMA和其他國家監管機構的批准需要進行廣泛的臨床驗證、品質合規性審查和上市後監測。這些流程將顯著延長產品上市時間，並增加製造商的研發成本，尤其是在分子即時檢測（POCT）和多重檢測等新興診斷技術領域。
- 成本限制也限制了發展中地區的普及，這些地區醫療預算有限，報銷體係不完善，難以廣泛部署。此外，維護需求、使用者培訓需求和工作流程整合等營運方面的挑戰也會阻礙醫院和診斷中心的大規模實施。
- 對檢測結果的準確性、可靠性和標準化的擔憂——尤其是在傳染病和心臟標記等高靈敏度檢測方面——可能會導致臨床醫生猶豫不決，並增加對集中式確診檢測的依賴。數位即時檢測平台的資料整合和網路安全問題也需要更完善的技術框架和投資。
- 隨著即時檢測（POCT）技術的不斷發展，克服這些財務、監管和技術方面的挑戰需要大量的研發資金投入、北美地區診斷標準的協調統一，以及設備製造商、醫療服務提供者和政府衛生機構之間的策略合作。在此之前，這些障礙可能會繼續限制某些市場領域和地區對POCT技術的接受速度。
北美即時檢測（POCT）市場範圍
市場按產品類型、平台、應用、處方模式、最終用戶和分銷管道進行細分。
- 依產品類型
根據產品類型，北美即時檢測（POCT）市場可細分為血糖監測產品、傳染病檢測產品、心血管代謝監測產品、妊娠和生育力檢測產品、血液學檢測產品、凝血監測產品、濫用藥物（DOA）檢測產品、尿液分析檢測產品、膽固醇檢測產品、腫瘤/癌症標誌物檢測產品、糞便隱血試驗產品及其他。預計到2026年，血糖監測產品細分市場將佔據最大的市場份額，達到38.86%，這主要得益於北美糖尿病負擔的加重、居家自我監測需求的增長以及血糖儀和互聯數位健康平台技術的不斷進步。
- 按平台
根據平台類型，北美即時檢測 (POCT) 市場可細分為側向層析/免疫層析檢測、免疫分析、試紙條、分子診斷、臨床化學檢測、微流控技術、血液學檢測及其他。預計到 2026 年，側向層析/免疫層析檢測將佔據主導地位，這主要得益於其在傳染病篩檢中的廣泛應用、易用性、快速出結果、低成本以及在 COVID-19、流感、瘧疾和登革熱等疫情爆發期間的廣泛使用。此外，其在分散式和遠距醫療環境中的適用性也進一步推動了該細分市場的成長。
- 透過申請
根據應用領域，北美即時檢測（POCT）市場可細分為血糖檢測、傳染病檢測、生命徵象監測、心臟監測、凝血檢測、血液學檢測、非侵入性血氧飽和度監測、輸血檢測、非侵入性二氧化碳分壓監測、全血分析及其他檢測。預計到2026年，血糖檢測將佔據最大的市場份額，這主要得益於糖尿病患病率的上升、患者對便攜式監測設備的需求增加，以及高精度、易用型血糖儀和持續血糖監測（CGM）技術的普及，這些技術支持即時糖尿病管理。
- 按處方模式
根據處方模式，北美即時檢測 (POCT) 市場可分為非處方檢測和處方檢測。由於消費者對自測解決方案的偏好日益增長、快速診斷試劑盒的普及以及對預防性醫療保健的日益重視，非處方檢測細分市場在 2026 年將佔據最大的市場份額。非處方 POCT 設備使個人無需臨床監督即可監測血糖水平、懷孕、生育能力、傳染病和心血管指標等健康參數。
- 最終用戶
根據最終用戶，北美即時檢測 (POCT) 市場可細分為醫院、家庭護理、診所、實驗室、診斷中心、病理實驗室、門診手術中心、老年護理中心和其他機構。預計到 2026 年，醫院細分市場將佔據最大的市場份額，這主要得益於對快速診斷檢測的旺盛需求，以支持急診護理、重症監護和常規臨床評估。血糖儀、心臟標記分析儀、傳染病快速檢測、凝血監測儀和血氣分析儀等 POCT 設備在醫院環境中得到越來越廣泛的應用，有助於加快臨床決策、縮短患者周轉時間並提高工作流程效率。
- 按分銷管道
根據分銷管道，北美即時檢測 (POCT) 市場可分為直接招標、零售、線上銷售和其他管道。到 2026 年，直接招標管道將佔據最大的市場份額，這主要得益於醫院、診斷實驗室和公共衛生機構對 POCT 設備的大量採購。大規模招標確保了常規檢測和急救所需的關鍵診斷工具（例如血糖儀、快速傳染病檢測試劑盒、心臟生物標記分析儀和凝血檢測設備）的穩定供應。
北美即時檢測（POCT）市場區域分析
- 北美地區在即時檢測（POCT）市場佔據主導地位，預計到2025年將佔據超過39.83%的市場份額，這主要得益於該地區醫療基礎設施的快速發展、慢性病負擔的加重以及分散式診斷技術的日益普及。美國、加拿大和墨西哥等國家對糖尿病、傳染病、心血管疾病以及居家監測的快速診斷試劑盒需求強勁。
- 對數位醫療的投資不斷增長、遠距醫療的擴展以及政府支持早期診斷的舉措，進一步加速了即時檢測（POCT）的部署。此外，龐大的老齡人口以及消費者對價格合理、快速醫療檢測日益增長的需求，也推動了該地區市場的成長。
美國北美即時檢測（POCT）市場洞察
2025年，美國憑藉其先進的醫療保健基礎設施、對疾病早期檢測的高度重視以及對居家診斷解決方案日益增長的偏好，在北美即時檢測（POCT）市場佔據主導地位。糖尿病、心臟病、呼吸系統疾病和傳染病的日益普遍，持續推動對快速檢測試劑盒的需求。強大的研發能力、互聯和智慧型手機整合檢測設備的高普及率以及成熟的監管環境，進一步促進了市場擴張。此外，個人化和即時診斷的趨勢，以及零售診所和藥局檢測的興起，也持續鞏固美國POCT市場的地位。
北美即時檢測 (POCT) 市佔率
即時檢測（POCT）產業主要由一些成熟的公司引領，包括：
- 雅培即時護理公司（美國）
- 信諾康股份有限公司（中國）
- F. Hoffmann-La Roche Ltd（瑞士）
- 丹納赫公司（美國）
- Hologic公司（美國）
- 生物梅里埃公司（法國）
- 西門子醫療股份公司（德國）
- 賽默飛世爾科技公司（美國）
- BD Veritor（貝克頓迪金森公司）（美國）
- QuidelOrtho公司（美國）
- Bio-Rad Laboratories, Inc.（美國）
- 韋爾芬（西班牙）
- 積水診斷（日本）
- Trividia Health, Inc.（美國）
- Nova Biomedical Corporation（美國）
- Meridian Bioscience, Inc.（美國）
- 輝瑞公司（美國）
- 深圳市新產業生物醫學工程有限公司（中國）
- Sysmex公司（日本）
- 萬孚生物（廣州萬孚生技有限公司）（中國）
- 凱傑公司（德國）
- Abaxis公司（美國）
- 奧特博診斷有限公司（中國）
- 吉泰生物科技有限公司（中國）
- Chembio Diagnostics, Inc.（美國）
- EKF Diagnostics Holdings plc（英國）
- Trinity Biotech plc（愛爾蘭）
- PTS Diagnostics（美國）
- QuantuMDx集團有限公司（英國）
- Binx Health（美國）
- 廈門博森生物科技有限公司（中國）
- 亞科生物科技有限公司（中國）
- Sienco公司（美國）
- LambdaGen公司（美國）
北美即時檢測（POCT）市場最新發展
- 2020年5月，雅培公司的ID NOW COVID-19快速檢測可在數分鐘內提供快速可靠的檢測結果，有助於及時診斷並降低感染風險。研究表明，該檢測在急診護理環境中表現出色，靈敏度≥94.7%，特異性≥98.6%。儘管紐約大學的一項研究提出了一些質疑，但真實世界數據支持其有效性。此檢測已獲得美國食品藥物管理局（FDA）的緊急使用授權，在COVID-19檢測中發揮至關重要的作用。
- 2025年9月，中科醫療旗下子公司東莞市億測科技有限公司的多系列智慧血壓計獲得美國FDA 510(k)認證，彰顯了其精準性、安全性和無線連線功能。該系列產品提供醫療級監測、藍牙連接和智慧警報功能，進一步鞏固了中科醫療在北美市場的擴張策略，並拓展了其在包括美國和歐洲在內的國際市場的慢性病管理系統。
- 2025年1月，丹納赫公司與醫療人工智慧公司Innovaccer Inc.建立了投資夥伴關係。此次合作旨在透過向醫療服務提供者提供統一的患者數據和進階分析，加速精準診斷和價值醫療的普及，並透過個人化、及時的干預措施改善患者預後。
- 2023年11月，Binx Health與Fisher Healthcare合作，擴大其獲得FDA批准的binx io的銷售範圍。 binx io是一種用於檢測披衣菌和淋病的分子即時檢測平台。該系統可在約30分鐘內提供實驗室級的檢測結果，從而提高診斷的及時性，並使臨床醫生能夠在一次就診中完成患者的檢測和治療，進而提升醫療服務的可及性。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 MULTIVARIATE MODELLING
2.6 TYPE LIFELINE CURVE
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 MARKET END USER COVERAGE GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 HEALTHCARE ECONOMY
4.3.1 HEALTHCARE EXPENDITURE
4.3.2 CAPITAL EXPENDITURE
4.3.3 CAPEX TRENDS
4.3.4 CAPEX ALLOCATION
4.3.5 FUNDING SOURCES
4.3.6 INDUSTRY BENCHMARKS
4.3.7 GDP RATIO IN OVERALL GDP
4.3.8 HEALTHCARE SYSTEM STRUCTURE
4.3.9 GOVERNMENT POLICIES
4.3.10 ECONOMIC DEVELOPMENT
4.4 REIMBURSEMENT FRAMEWORK
4.5 OPPORTUNITY MAP ANALYSIS
4.6 VALUE CHAIN ANALYSIS
4.7 MICRO AND MACRO ECONOMIC FACTORS
4.7.1 CURRENT MARKET PENETRATION
4.7.2 GROWTH PROSPECTS
4.7.3 KEY PRICING STRATEGIES
4.8 TECHNOLOGY ROADMAP: NORTH AMERICA POINT OF CARE TESTING
5 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING USE OF POC TESTING IN HEALTHCARE FACILITIES
6.1.2 RISING INCIDENCE OF SUBSTANCE ABUSE
6.1.3 INCREASED ADOPTION OF TELEMEDICINE
6.1.4 ADVANCEMENTS TECHNOLOGIES ENHANCING POC TESTING WITH BIOSENSORS AND MOBILE INTEGRATION
6.2 RESTRAINTS
6.2.1 DATA SECURITY AND PRIVACY CONCERNS
6.2.2 LACK OF ACCURACY AND TECHNICAL CHALLENGES
6.3 OPPORTUNITIES
6.3.1 RISING AWARENESS AND ADVOCACY FOR POINT-OF-CARE TESTING
6.3.2 STRATEGIC INITIATION AND DECISION TAKEN BY THE MARKET PLAYERS
6.3.3 EXPANDING PRODUCT RANGE FOR POINT-OF-CARE TESTING
6.4 CHALLENGES
6.4.1 LIMITED AWARENESS AND ACCEPTANCE
6.4.2 IMPACT OF HIGH MAINTENANCE COSTS THREATENING POINT-OF-CARE TESTING (POCT) SUSTAINABILITY IN LOW-RESOURCE SETTINGS
7 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 GLUCOSE MONITORING PRODUCTS
7.2.1 SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES
7.2.1.1 Strips
7.2.1.2 Meters
7.2.1.3 Lancets and Lancing Devices
7.2.2 CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS
7.3 INFECTIOUS DISEASE TESTING PRODUCTS
7.3.1 COVID-19
7.3.2 HIV TESTING PRODUCTS
7.3.2.1 Testing Reagents
7.3.2.2 Testing Equipment
7.3.3 RESPIRATORY INFECTION TESTING PRODUCTS
7.3.4 SEXUALLY TRANSMITTED DISEASES (STD) TESTING
7.3.4.1 NAAT-Based Systems
7.3.4.2 NON–NAAT-Based Systems
7.3.5 HEPATITIS C TESTING PRODUCTS
7.3.5.1 HCV Antibody Tests
7.3.5.2 HCV Viral Load Tests
7.3.6 INFLUENZA TESTING PRODUCTS
7.3.6.1 Traditional Diagnostic Test
7.3.6.2 Molecular Diagnostic Assay
7.3.6.2.1 Rapid Influenza Diagnostic Test (RIDT)
7.3.6.2.2 Direct Fluorescent Antibody Test (DFAT)
7.3.6.2.3 Viral Culture
7.3.6.2.4 Serological Assay
7.3.6.3 RT-PCR
7.3.6.4 Loop-Mediated Isothermal Amplification-Based Assay (LAMP)
7.3.6.5 Nucleic Acid Sequence-Based Amplification Test (NASBAT)
7.3.6.6 Simple Amplification-Based Assay (SAMBA)
7.3.6.7 Healthcare Associated Infection (HAI) Testing
7.3.6.8 Tropical Disease Testing Products
7.3.6.9 Other Infectious Disease Testing Products
7.4 CARDIOMETABOLIC MONITORING PRODUCTS
7.4.1 CARDIAC MARKER TESTING PRODUCTS
7.4.1.1 HSTNL
7.4.1.2 BNP
7.4.1.3 D-DIMER
7.4.1.4 CK-MB
7.4.1.5 Myoglobin
7.4.2 BLOOD GAS/ELECTROLYTE TESTING PRODUCTS
7.4.2.1 Blood Gas/Electrolyte Testing Consumables
7.4.2.2 Blood Gas/Electrolyte Testing Instruments
7.4.3 CARTRIDGES
7.4.4 REAGENTS
7.4.4.1 Portable
7.4.4.2 Benchtop
7.4.4.3 Combined Analyzers
7.4.4.4 Blood Gas Analyzers
7.4.4.5 Electrolyte Analyzers
7.4.4.6 Combined Analyzers
7.4.4.7 Blood Gas Analyzers
7.4.4.8 Electrolyte Analyzers
7.4.5 HBA1C TESTING PRODUCTS
7.4.5.1 HBA1C Testing Instruments
7.4.5.2 HBA1C Testing Consumables
7.4.5.3 POC Analyzer
7.4.5.4 ECG Device
7.4.5.5 Resting ECG Devices
7.4.5.6 Stress ECG Devices
7.4.5.7 Holter Monitors
7.5 PREGNANCY AND FERTILITY TESTING PRODUCTS
7.5.1 PREGNANCY TESTING PRODUCTS
7.5.1.1 Strips/ Dip Sticks and Cards
7.5.1.2 Mid Stream Devices
7.5.1.3 Cassettes
7.5.1.4 Digital Devices
7.5.1.5 Line-Indicator Devices
7.5.2 FERTILITY TESTING PRODUCTS
7.5.2.1 Luteinizing Hormone (LH) Urine Test
7.5.2.2 FSH Test
7.5.2.3 others
7.6 HAEMATOLOGY TESTING PRODUCTS
7.7 COAGULATION MONITORING PRODUCTS
7.7.1 ANTICOAGULATION MONITORING DEVICES
7.7.1.1 Prothrombin Time/International Normalized Ratio (PT-INR) Testing Devices
7.7.1.2 Activated Clotting Time (ACT)
7.7.1.3 Activated Partial Thromboplastin Time (APPT)
7.7.1.4 Platelet Function Monitoring Devices
7.7.1.5 Viscoelastic Coagulation Monitoring Devices
7.7.1.6 Rotational Thromboelastometry (ROTEM)
7.7.1.7 Thromboelastography (TEG)
7.7.1.8 Drug-Of-Abuse (DOA) Testing Products
7.7.2 DOA ANALYSERS
7.7.2.1 Immunoassays
7.7.2.2 Chromatographic Devices
7.7.2.3 Breath Analysers
7.7.3 RAPID TESTING DEVICES
7.7.3.1 Urine Testing Devices
7.7.3.2 Oral Fluid Testing Devices
7.7.3.4 Others
7.8 URINALYSIS TESTING PRODUCTS
7.8.1.1 POC Urine Strip Self-Testing
7.8.1.2 POC Urine Test Strip Professional Testing
7.9 CHOLESTEROL TESTING PRODUCTS
7.9.1.1 Testing Kits
7.9.1.2 Instruments
7.9.1.3 Table-Top Analyzers
7.9.1.4 Hand-Held Analyzers
7.1 TUMOR/CANCER MARKER TESTING PRODUCTS
7.11 FECAL OCCULT TESTING PRODUCTS
7.11.1.1 Guaiac FOB Stool Test
7.11.1.2 Lateral Flow Immuno-FOB Test
7.11.1.3 Immuno-FOB Agglutination Test
7.11.1.4 Immuno-FOB ELISA Test
7.12 OTHERS
8 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET, BY PLATFORM
8.1 OVERVIEW
8.2 LATERAL FLOW ASSAYS/IMMUNOCHROMATOGRAPHY TESTS
8.3 IMMUNOASSAYS
8.4 DIPSTICKS
8.5 MOLECULAR DIAGNOSTICS
8.6 CLINICAL CHEMISTRY ASSAYS
8.7 MICROFLUIDICS
8.8 HEMATOLOGY
8.9 OTHERS
9 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 BLOOD GLUCOSE
9.3 INFECTIOUS DISEASES
9.3.1 COVID-19 TESTING
9.3.2 HIV TESTING
9.3.3 HEPATITIS C TESTING
9.3.4 INFLUENZA TESTING
9.3.5 TUBERCULOSIS TESTING
9.3.6 OTHERS
9.4 VITAL SIGN MONITORING
9.5 CARDIAC MONITORING
9.6 COAGULATION
9.7 HAEMATOLOGY
9.8 NON- INVASIVE SPO2 MONITORING
9.9 BLOOD TRANSFUSION
9.1 NON- INVASIVE PCO2 MONITORING
9.11 WHOLE BLOOD ANALYSIS
9.12 OTHERS
10 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE
10.1 OVERVIEW
10.2 OTC TESTING
10.3 PRESCRIPTION-BASED TESTING
11 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
11.4 ONLINE SALES
11.5 OTHERS
12 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.2.1 PRIVATE
12.2.1.1 Tier 1
12.2.1.2 Tier 2
12.2.1.3 Tier 3
12.2.2 PUBLIC
12.2.2.1 Tier 1
12.2.2.2 Tier 2
12.2.2.3 Tier 3
12.3 HOME CARE
12.4 CLINICS
12.5 LABORATORIES
12.6 DIAGNOSTIC CENTERS
12.7 PATHOLOGY LABS
12.8 AMBULATORY SURGERY CENTERS
12.9 ELDERLY CARE CENTERS
12.1 OTHERS
13 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: GLOBAL
15 SWOT ANALYSIS
16 COMPANY PROFILES
16.1 ABBOTT POINT OF CARE INC(ABBOTT)
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 SINOCARE.
16.2.1 COMPANY SNAPSHOT
16.2.2 COMPANY SHARE ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPMENT
16.3 F. HOFFMANN-LA ROCHE LTD
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENT
16.4 DANAHER
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 HOLOGIC, INC
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENT
16.6 ACCUBIOTECH CO., LTD.
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 ABAXIS (ABAXIS IS A PART OF ZOETIS)
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
16.8 AUTOBIO
16.8.1 COMPANY SNAPSHOT
16.8.2 REVENUE ANALYSIS
16.8.3 PRODUCT PORTFOLIO
16.8.4 RECENT DEVELOPMENT
16.9 BD VERITOR(BD)
16.9.1 COMPANY SNAPSHOT
16.9.2 REVENUE ANALYSIS
16.9.3 PRODUCT PORTFOLIO
16.9.4 RECENT DEVELOPMENT
16.1 BINX HEALTH
16.10.1 COMPANY SNAPSHOT
16.10.2 SOLUTION PORTFOLIO
16.10.3 RECENT DEVELOPMENT
16.11 BIOMERIEUX
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 PRODUCT PORTFOLIO
16.11.4 RECENT DEVELOPMENT
16.12 BIO- RAD LABORATORIES, INC.
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.4 RECENT DEVELOPMENT
16.13 CHEMBIO DIAGNOSTICS, INC.
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 EKF DIAGNOSTICS HOLDINGS PLC
16.14.1 COMPANY SNAPSHOT
16.14.2 REVENUE ANALYSIS
16.14.3 PRODUCT PORTFOLIO
16.14.4 RECENT DEVELOPMENT
16.15 GETEIN BIOTECH, INC.
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENT
16.16 LAMDAGEN CORPORATION
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 MERIDIAN BIOSCIENCE
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENT
16.18 NOVA BIOMEDICAL
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENT
16.19 PFIZER INC.
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 PTS DIAGNOSTICS
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 QIAGEN
16.21.1 COMPANY SNAPSHOT
16.21.2 REVENUE ANALYSIS
16.21.3 PRODUCT PORTFOLIO
16.21.4 RECENT DEVELOPMENT
16.22 QUIDELORTHO CORPORATION
16.22.1 COMPANY SNAPSHOT
16.22.2 REVENUE ANALYSIS
16.22.3 PRODUCT PORTFOLIO
16.22.4 RECENT DEVELOPMENT
16.23 QUANTUMDX GROUP LTD.
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENT
16.24 SEKISUI DIAGNOSTICS
16.24.1 COMPANY SNAPSHOT
16.24.2 PRODUCT PORTFOLIO
16.24.3 RECENT. DEVELOPMENT
16.25 SHENZHEN NEW INDUSTRY BIOMEDICAL ENGINEERING CO., LTD.
16.25.1 COMPANY SNAPSHOT
16.25.2 REVENUE ANALYSIS
16.25.3 PRODUCT PORTFOLIO
16.25.4 RECENT DEVELOPMENT
16.26 SIEMENS HEALTHINEERS AG
16.26.1 COMPANY SNAPSHOT
16.26.2 REVENUE ANALYSIS
16.26.3 PRODUCT PORTFOLIO
16.26.4 RECENT DEVELOPMENT
16.27 SIENCO, INC.
16.27.1 COMPANY SNAPSHOT
16.27.2 PRODUCT PORTFOLIO
16.27.3 RECENT UPDATES
16.28 SYSMEX CORPORATION
16.28.1 COMPANY SNAPSHOT
16.28.2 REVENUE ANALYSIS
16.28.3 PRODUCT PORTFOLIO
16.28.4 RECENT DEVELOPMENT
16.29 TRINITY BIOTECH
16.29.1 COMPANY SNAPSHOT
16.29.2 REVENUE ANALYSIS
16.29.3 PR.ODUCT PORTFOLIO
16.29.4 RECENT DEVELOPMENT
16.3 TRIVIDIA HEALTH, INC.
16.30.1 COMPANY SNAPSHOT
16.30.2 PRODUCT PORTFOLIO
16.30.3 RECENT UPDATES
16.31 THERMO FISHER SCIENTIFIC INC.
16.31.1 COMPANY SNAPSHOT
16.31.2 REVENUE ANALYSIS
16.31.3 PRODUCT PORTFOLIO
16.31.4 RECENT DEVELOPMENT
16.32 WERFEN
16.32.1 COMPANY SNAPSHOT
16.32.2 PRODUCT PORTFOLIO
16.32.3 RECENT DEVELOPMENT
16.33 WONDFO
16.33.1 COMPANY SNAPSHOT
16.33.2 REVENUE ANALYSIS
16.33.3 PRODUCT PORTFOLIO
16.33.4 RECENT DEVELOPMENT
16.34 XIAMEN BOSON BIOTECH CO., LTD.
16.34.1 COMPANY SNAPSHOT
16.34.2 PRODUCT PORTFOLIO
16.34.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
表格列表
TABLE 1 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 3 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 4 NORTH AMERICA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 5 NORTH AMERICA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 6 NORTH AMERICA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 7 NORTH AMERICA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 8 NORTH AMERICA SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 9 NORTH AMERICA SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 10 NORTH AMERICA SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 11 NORTH AMERICA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 12 NORTH AMERICA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSANDS)
TABLE 13 NORTH AMERICA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSANDS UNITS)
TABLE 14 NORTH AMERICA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 15 NORTH AMERICA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 16 NORTH AMERICA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 17 NORTH AMERICA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 18 NORTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 19 NORTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 20 NORTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 21 NORTH AMERICA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSANDS)
TABLE 22 NORTH AMERICA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 23 NORTH AMERICA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 24 NORTH AMERICA INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 25 NORTH AMERICA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 26 NORTH AMERICA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 27 NORTH AMERICA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 28 NORTH AMERICA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 29 NORTH AMERICA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 30 NORTH AMERICA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 31 NORTH AMERICA CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 32 NORTH AMERICA CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 33 NORTH AMERICA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 34 NORTH AMERICA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 35 NORTH AMERICA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 36 NORTH AMERICA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 37 NORTH AMERICA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 38 NORTH AMERICA BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 39 NORTH AMERICA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 40 NORTH AMERICA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 41 NORTH AMERICA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 42 NORTH AMERICA BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 43 NORTH AMERICA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 44 NORTH AMERICA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 45 NORTH AMERICA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 46 NORTH AMERICA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSANDS)
TABLE 47 NORTH AMERICA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 48 NORTH AMERICA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 49 NORTH AMERICA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 50 NORTH AMERICA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 51 NORTH AMERICA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 52 NORTH AMERICA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 53 NORTH AMERICA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 54 NORTH AMERICA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 55 NORTH AMERICA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 56 NORTH AMERICA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 57 NORTH AMERICA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 58 NORTH AMERICA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSANDS UNITS)
TABLE 59 NORTH AMERICA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 60 NORTH AMERICA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 61 NORTH AMERICA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 62 NORTH AMERICA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 63 NORTH AMERICA HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 64 NORTH AMERICA COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSANDS)
TABLE 65 NORTH AMERICA COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSANDS)
TABLE 66 NORTH AMERICA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 67 NORTH AMERICA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 68 NORTH AMERICA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 69 NORTH AMERICA VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2033 (USD THOUSANDS)
TABLE 70 NORTH AMERICA DRUGS-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 71 NORTH AMERICA DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 72 NORTH AMERICA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSANDS)
TABLE 73 NORTH AMERICA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 74 NORTH AMERICA DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 75 NORTH AMERICA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 76 NORTH AMERICA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 77 NORTH AMERICA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 78 NORTH AMERICA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 79 NORTH AMERICA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 80 NORTH AMERICA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 81 NORTH AMERICA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 82 NORTH AMERICA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 83 NORTH AMERICA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 84 NORTH AMERICA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSANDS UNITS)
TABLE 85 NORTH AMERICA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 86 NORTH AMERICA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSANDS)
TABLE 87 NORTH AMERICA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 88 NORTH AMERICA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 89 NORTH AMERICA TUMOR/CANCER MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 90 NORTH AMERICA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 91 NORTH AMERICA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 92 NORTH AMERICA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSANDS UNITS)
TABLE 93 NORTH AMERICA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 94 NORTH AMERICA OTHERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 95 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2033 (USD THOUSAND)
TABLE 96 NORTH AMERICA LATERAL FLOW ASSAYS/IMMUNOCHROMATOGRAPHY TESTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSANDS)
TABLE 97 NORTH AMERICA IMMUNOASSAYS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSANDS)
TABLE 98 NORTH AMERICA DIPSTICKS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSANDS)
TABLE 99 NORTH AMERICA MOLECULAR DIAGNOSTICS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSANDS)
TABLE 100 NORTH AMERICA CLINICAL CHEMISTRY ASSAYS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 101 NORTH AMERICA MICROFLUIDICS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSANDS)
TABLE 102 NORTH AMERICA HEMATOLOGY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSANDS)
TABLE 103 NORTH AMERICA OTHERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSANDS)
TABLE 104 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 105 NORTH AMERICA BLOOD GLUCOSE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 106 NORTH AMERICA INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 107 NORTH AMERICA INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 108 NORTH AMERICA VITAL SIGN MONITORING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 109 NORTH AMERICA CARDIAC MONITORING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 110 NORTH AMERICA COAGULATION IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 111 NORTH AMERICA HAEMATOLOGY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 112 NORTH AMERICA NON-INVASIVE SPO2 MONITORING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 113 NORTH AMERICA BLOOD TRANSFUSION IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 114 NORTH AMERICA NON-INVASIVE PCO2 MONITORING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 115 NORTH AMERICA WHOLE BLOOD ANALYSIS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 116 NORTH AMERICA OTHERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 117 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2033 (USD THOUSANDS)
TABLE 118 NORTH AMERICA OTC TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 119 NORTH AMERICA PRESCRIPTION-BASED TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSANDS)
TABLE 120 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD MILLION)
TABLE 121 NORTH AMERICA DIRECT TENDER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD MILLIONS)
TABLE 122 NORTH AMERICA RETAIL SALES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD MILLIONS)
TABLE 123 NORTH AMERICA ONLINE SALES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD MILLIONS)
TABLE 124 NORTH AMERICA OTHERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD MILLIONS)
TABLE 125 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 126 NORTH AMERICA HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2032 (USD THOUSANDS)
TABLE 127 NORTH AMERICA HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSANDS)
TABLE 128 NORTH AMERICA PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSANDS)
TABLE 129 NORTH AMERICA PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSANDS)
TABLE 130 NORTH AMERICA HOME CARE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 131 NORTH AMERICA CLINICS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 132 NORTH AMERICA LABORATORIES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 133 NORTH AMERICA DIAGNOSTIC CENTERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 134 NORTH AMERICA PATHOLOGY LABS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 135 NORTH AMERICA AMBULATORY SURGERY CENTERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 136 NORTH AMERICA ELDERLY CARE CENTERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 137 NORTH AMERICA OTHERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 138 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 139 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 140 NORTH AMERICA
TABLE 141 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 142 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 143 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 144 NORTH AMERICA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 145 NORTH AMERICA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 146 NORTH AMERICA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 147 NORTH AMERICA SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 148 NORTH AMERICA SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 149 NORTH AMERICA SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 150 NORTH AMERICA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 151 NORTH AMERICA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 152 NORTH AMERICA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 153 NORTH AMERICA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 154 NORTH AMERICA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 155 NORTH AMERICA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 156 NORTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 157 NORTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 158 NORTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 159 NORTH AMERICA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 160 NORTH AMERICA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 161 NORTH AMERICA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 162 NORTH AMERICA INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 163 NORTH AMERICA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 164 NORTH AMERICA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 165 NORTH AMERICA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 166 NORTH AMERICA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 167 NORTH AMERICA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 168 NORTH AMERICA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 169 NORTH AMERICA CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 170 NORTH AMERICA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 171 NORTH AMERICA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 172 NORTH AMERICA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 173 NORTH AMERICA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 174 NORTH AMERICA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 175 NORTH AMERICA BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 176 NORTH AMERICA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 177 NORTH AMERICA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 178 NORTH AMERICA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 179 NORTH AMERICA BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 180 NORTH AMERICA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 181 NORTH AMERICA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 182 NORTH AMERICA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 183 NORTH AMERICA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 184 NORTH AMERICA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 185 NORTH AMERICA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 186 NORTH AMERICA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 187 NORTH AMERICA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 188 NORTH AMERICA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 189 NORTH AMERICA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 190 NORTH AMERICA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 191 NORTH AMERICA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 192 NORTH AMERICA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 193 NORTH AMERICA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 194 NORTH AMERICA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 195 NORTH AMERICA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 196 NORTH AMERICA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 197 NORTH AMERICA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 198 NORTH AMERICA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 199 NORTH AMERICA COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 200 NORTH AMERICA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 201 NORTH AMERICA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 202 NORTH AMERICA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 203 NORTH AMERICA VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2033 (USD THOUSAND)
TABLE 204 NORTH AMERICA DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 205 NORTH AMERICA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 206 NORTH AMERICA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 207 NORTH AMERICA DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 208 NORTH AMERICA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 209 NORTH AMERICA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 210 NORTH AMERICA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 211 NORTH AMERICA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 212 NORTH AMERICA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 213 NORTH AMERICA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 214 NORTH AMERICA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 215 NORTH AMERICA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 216 NORTH AMERICA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 217 NORTH AMERICA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 218 NORTH AMERICA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 219 NORTH AMERICA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 220 NORTH AMERICA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 221 NORTH AMERICA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 222 NORTH AMERICA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 223 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2033 (USD THOUSAND)
TABLE 224 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 225 NORTH AMERICA INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 226 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2033 (USD THOUSAND)
TABLE 227 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 228 NORTH AMERICA HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 229 NORTH AMERICA PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)
TABLE 230 NORTH AMERICA PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)
TABLE 231 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 232 U.S. POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 233 U.S. POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 234 U.S. POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 235 U.S. GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 236 U.S. GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 237 U.S. GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 238 U.S. SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 239 U.S. SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 240 U.S. SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 241 U.S. INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 242 U.S. INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 243 U.S. INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 244 U.S. HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 245 U.S. HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 246 U.S. HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 247 U.S. SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 248 U.S. SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 249 U.S. SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 250 U.S. HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 251 U.S. HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 252 U.S. HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 253 U.S. INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 254 U.S. TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 255 U.S. TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 256 U.S. TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 257 U.S. MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 258 U.S. MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 259 U.S. MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 260 U.S. CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 261 U.S. POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 262 U.S. POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 263 U.S. CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 264 U.S. CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 265 U.S. CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 266 U.S. BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 267 U.S. BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 268 U.S. BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 269 U.S. BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 270 U.S. BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 271 U.S. PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 272 U.S. PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 273 U.S. PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 274 U.S. BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 275 U.S. BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 276 U.S. BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 277 U.S. HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 278 U.S. HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 279 U.S. HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 280 U.S. ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 281 U.S. ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 282 U.S. ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 283 U.S. PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 284 U.S. PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 285 U.S. PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 286 U.S. PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 287 U.S. FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 288 U.S. FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 289 U.S. FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 290 U.S. COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 291 U.S. ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 292 U.S. ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 293 U.S. ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 294 U.S. VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2033 (USD THOUSAND)
TABLE 295 U.S. DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 296 U.S. DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 297 U.S. DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 298 U.S. DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 299 U.S. RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 300 U.S. RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 301 U.S. RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 302 U.S. URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 303 U.S. URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 304 U.S. URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 305 U.S. CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 306 U.S. CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 307 U.S. CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 308 U.S. INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 309 U.S. INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 310 U.S. INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 311 U.S. FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 312 U.S. FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 313 U.S. FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 314 U.S. POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2033 (USD THOUSAND)
TABLE 315 U.S. POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 316 U.S. INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 317 U.S. POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2033 (USD THOUSAND)
TABLE 318 U.S. POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 319 U.S. HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 320 U.S. PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)
TABLE 321 U.S. PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)
TABLE 322 U.S. POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 323 CANADA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 324 CANADA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 325 CANADA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 326 CANADA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 327 CANADA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 328 CANADA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 329 CANADA SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 330 CANADA SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 331 CANADA SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 332 CANADA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 333 CANADA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 334 CANADA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 335 CANADA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 336 CANADA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 337 CANADA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 338 CANADA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 339 CANADA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 340 CANADA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 341 CANADA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 342 CANADA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 343 CANADA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 344 CANADA INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 345 CANADA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 346 CANADA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 347 CANADA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 348 CANADA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 349 CANADA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 350 CANADA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 351 CANADA CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 352 CANADA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 353 CANADA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 354 CANADA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 355 CANADA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 356 CANADA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 357 CANADA BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 358 CANADA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 359 CANADA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 360 CANADA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 361 CANADA BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 362 CANADA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 363 CANADA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 364 CANADA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 365 CANADA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 366 CANADA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 367 CANADA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 368 CANADA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 369 CANADA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 370 CANADA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 371 CANADA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 372 CANADA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 373 CANADA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 374 CANADA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 375 CANADA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 376 CANADA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 377 CANADA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 378 CANADA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 379 CANADA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 380 CANADA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 381 CANADA COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 382 CANADA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 383 CANADA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 384 CANADA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 385 CANADA VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2033 (USD THOUSAND)
TABLE 386 CANADA DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 387 CANADA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 388 CANADA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 389 CANADA DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 390 CANADA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 391 CANADA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 392 CANADA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 393 CANADA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 394 CANADA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 395 CANADA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 396 CANADA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 397 CANADA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 398 CANADA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 399 CANADA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 400 CANADA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 401 CANADA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 402 CANADA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 403 CANADA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 404 CANADA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 405 CANADA POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2033 (USD THOUSAND)
TABLE 406 CANADA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 407 CANADA INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 408 CANADA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2033 (USD THOUSAND)
TABLE 409 CANADA POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 410 CANADA HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 411 CANADA PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)
TABLE 412 CANADA PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)
TABLE 413 CANADA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 414 MEXICO POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 415 MEXICO POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 416 MEXICO POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 417 MEXICO GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 418 MEXICO GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 419 MEXICO GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 420 MEXICO SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 421 MEXICO SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 422 MEXICO SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 423 MEXICO INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 424 MEXICO INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 425 MEXICO INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 426 MEXICO HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 427 MEXICO HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 428 MEXICO HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 429 MEXICO SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 430 MEXICO SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 431 MEXICO SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 432 MEXICO HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 433 MEXICO HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 434 MEXICO HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 435 MEXICO INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 436 MEXICO TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 437 MEXICO TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 438 MEXICO TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 439 MEXICO MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 440 MEXICO MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 441 MEXICO MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 442 MEXICO CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 443 MEXICO POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 444 MEXICO POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 445 MEXICO CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 446 MEXICO CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 447 MEXICO CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 448 MEXICO BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 449 MEXICO BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 450 MEXICO BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 451 MEXICO BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 452 MEXICO BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 453 MEXICO PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 454 MEXICO PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 455 MEXICO PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 456 MEXICO BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 457 MEXICO BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 458 MEXICO BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 459 MEXICO HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 460 MEXICO HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 461 MEXICO HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 462 MEXICO ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 463 MEXICO ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 464 MEXICO ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 465 MEXICO PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 466 MEXICO PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 467 MEXICO PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 468 MEXICO PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 469 MEXICO FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 470 MEXICO FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 471 MEXICO FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 472 MEXICO COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 473 MEXICO ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 474 MEXICO ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 475 MEXICO ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 476 MEXICO VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2033 (USD THOUSAND)
TABLE 477 MEXICO DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 478 MEXICO DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 479 MEXICO DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 480 MEXICO DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 481 MEXICO RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 482 MEXICO RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 483 MEXICO RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 484 MEXICO URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 485 MEXICO URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 486 MEXICO URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 487 MEXICO CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 488 MEXICO CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 489 MEXICO CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 490 MEXICO INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 491 MEXICO INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 492 MEXICO INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 493 MEXICO FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 494 MEXICO FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)
TABLE 495 MEXICO FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)
TABLE 496 MEXICO POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2033 (USD THOUSAND)
TABLE 497 MEXICO POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 498 MEXICO INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 499 MEXICO POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2033 (USD THOUSAND)
TABLE 500 MEXICO POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 501 MEXICO HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 502 MEXICO PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)
TABLE 503 MEXICO PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)
TABLE 504 MEXICO POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
图片列表
FIGURE 1 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET: REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET: SEGMENTATION
FIGURE 11 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET EXECUTIVE SUMMARY
FIGURE 12 STRATEGIC DECISIONS
FIGURE 13 RISING USE OF POC TESTING IN HEALTHCARE FACILITIES IS EXPECTED TO DRIVE THE GROWTH OF NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET FROM 2026 TO 2033
FIGURE 14 THE GLUCOSE MONITORING PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET IN 2026 - 2032
FIGURE 15 DRCO ANALYSIS
FIGURE 16 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2025
FIGURE 17 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2026-2033 (USD THOUSAND)
FIGURE 18 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, CAGR (2026-2033)
FIGURE 19 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 20 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2025
FIGURE 21 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2026 TO 2033 (USD THOUSAND)
FIGURE 22 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, CAGR (2026- 2033)
FIGURE 23 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, LIFELINE CURVE
FIGURE 24 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2025
FIGURE 25 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2026 TO 2033 (USD THOUSAND)
FIGURE 26 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, CAGR (2026- 2033)
FIGURE 27 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 28 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2025
FIGURE 29 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2026 TO 2033 (USD THOUSAND)
FIGURE 30 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, CAGR (2026- 2033)
FIGURE 31 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, LIFELINE CURVE
FIGURE 32 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2025
FIGURE 33 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2026 TO 2033 (USD THOUSAND)
FIGURE 34 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2026- 2033)
FIGURE 35 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 36 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2025
FIGURE 37 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2026 TO 2033 (USD THOUSAND)
FIGURE 38 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, CAGR (2026- 2033)
FIGURE 39 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, LIFELINE CURVE
FIGURE 40 NORTH AMERICA POINT-OF-CARE-TESTING (POCT) MARKET: SNAPSHOT
FIGURE 41 NORTH AMERICA POINT-OF-CARE TESTING (POCT) MARKET: COMPANY SHARE 2025 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
